HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

MF 438

inhibits stearoyl-CoA desaturase 1; structure in first source

Also Known As:

MF-438; MF438 cpd

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Thiazoles: 392
      - Thiadiazoles: 99
        MF 438: 3
  - Pyridazines: 11
    - MF 438: 3
Organic Chemicals: 133
- Sulfur Compounds: 278
  - Thiazoles: 392
    - Thiadiazoles: 99
      - MF 438: 3

Experts

1.	Koskela, Ali: 1 article (01/2022)
2.	Lewin-Kowalik, Joanna: 1 article (01/2022)
3.	Machowicz, Joanna: 1 article (01/2022)
4.	Mrukwa-Kominek, Ewa: 1 article (01/2022)
5.	Pacwa, Anna: 1 article (01/2022)
6.	Pietrucha-Dutczak, Marita: 1 article (01/2022)
7.	Smedowski, Adrian: 1 article (01/2022)
8.	Toropainen, Elisa: 1 article (01/2022)
9.	Wojtyniak, Alicja: 1 article (01/2022)
10.	Ascierto, Paolo A: 1 article (12/2018)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2022 - "Tumor cell ferroptosis and ICD was analyzed in MF-438, radiation therapy (RT) and the combination treatment group. "
2.	Melanoma (Melanoma, Malignant) 12/17/2018 - "The effects of combination of BRAF/MEKi and the SCD1 inhibitor MF-438 were monitored by spheroid-forming and proliferation assays on a panel of BRAF-mutated melanoma cell lines grown in 3D and 2D conditions, respectively. "
3.	Inflammation (Inflammations) 01/01/2022 - "SCD1-Fatty Acid Desaturase Inhibitor MF-438 Alleviates Latent Inflammation Induced by Preservative-Free Prostaglandin Analog Eye Drops."

Related Drugs and Biologics

1.	Synthetic Prostaglandins (Prostaglandin Analogues)
2.	Ophthalmic Solutions (Eye Drops)
3.	Acids

Related Therapies and Procedures

1.	Radiotherapy